1 Zanella A,Barcellini W. Treatment of autoimmune hemolytic anemias[J]. Haematologica,2014,99(10):1547-1554.
2 Bass G F,Tuscano E T,Tuscano J M. Diagnosis and classification of autoimmune hemolytic anemia[J]. Autoimmun Rev,2014,13(4-5):560-564.
3 Dimitrijevic M,Kotur-Stevuljevic J,Stojic-Vukanic Z,et al. Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis:Relation to Neurological Deficit[J]. Neurochem Res,2017,42(2):481-492.
4 Mateen S,Moin S,Khan A Q,et al. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis[J]. PLoS One,2016,11(4):e0152925.
5 Kumar V,Rahman S,Choudhry H,et al. Computing disease-linked SOD1 mutations:deciphering protein stability and patient-phenotype relations[J]. Sci Rep,2017,7(1):4678.
6 Iuchi Y,Kibe N,Tsunoda S,et al. Implication of oxidative stress as a cause of autoimmune hemolytic anemia in NZB mice[J]. Free Radic Biol Med,2010,48(7):935-944.
7 Otsuki N,Konno T,Kurahashi T,et al. The SOD1 transgene expressed in erythroid cells alleviates fatal phenotype in congenic NZB/NZW-F1 mice[J]. Free Radic Res,2016,50(7):793-800.
8 Cluitmans J C,Gevi F,Siciliano A,et al. Red Blood Cell Homeostasis:Pharmacological Interventions to Explore Biochemical,Morphological and Mechanical Properties[J]. Front Mol Biosci,2016,3:10.
9 Higashi D L,Biais N,Donahue D L,et al. Activation of band 3 mediates group A Streptococcus streptolysin S-based beta-haemolysis[J]. Nat Microbiol,2016,1:115004.
10 Janvier D,Lam Y,Lopez I,et al. A major target for warm immunoglobulin G autoantibodies:the third external loop of Band 3[J]. Transfusion,2013,53(9):1948-1955.
11 Bergmeier W,Weidinger C,Zee I,et al. Emerging roles of store-operated Ca(2)(+) entry through STIM and ORAI proteins in immunity,hemostasis and cancer[J]. Channels (Austin),2013,7(5):379-391.
12 McNally B A,Somasundaram A,Yamashita M,et al. Gated regulation of CRAC channel ion selectivity by STIM1[J]. Nature,2012,482(7384):241-245.
13 Cheng K T,Alevizos I,Liu X,et al. STIM1 and STIM2 protein deficiency in T lymphocytes underlies development of the exocrine gland autoimmune disease,Sjogren's syndrome[J]. Proc Natl Acad Sci U S,2012,109(36):14544-14549.
14 Sogkas G,Stegner D,Syed S N,et al. Cooperative and alternate functions for STIM1 and STIM2 in macrophage activation and in the context of inflammation[J]. Immun Inflamm Dis,2015,3(3):154-170.
15 Delgado J,Doubek M,Baumann T,et al. Chronic lymphocytic leukemia:A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI[J]. Am J Hematol,2017,92(4):375-380.
16 Maura F,Visco C,Falisi E,et al. B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia[J]. Am J Hematol,2013,88(1):32-36.
17 Le X,Yu X,Shen N. Novel insights of microRNAs in the development of systemic lupus erythematosus[J]. Curr Opin Rheumatol,2017,29(5):450-457.
18 Lin C E,Kaptein J S,Sheikh J. Differential expression of microRNAs and their possible roles in patients with chronic idiopathic urticaria and active hives[J]. Allergy Rhinol (Providence),2017,8(2):67-80.
19 Ferrer G,Navarro A,Hodgson K,et al. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia[J]. Leuk Lymphoma,2013,54(9):2016-2022.
20 Klimatcheva E,Pandina T,Reilly C,et al. CXCL13 antibody for the treatment of autoimmune disorders[J]. BMC Immunol,2015,16(1):6.
21 Wu B,Wang W,Zhan Y,et al. CXCL13,CCL4,and sTNFR as circulating inflammatory cytokine markers in primary and SLE-related autoimmune hemolytic anemia[J]. J Transl Med,2015,13:112. |
